|
Originally published In Press as doi:10.1194/jlr.M300422-JLR200 on January 16, 2004
Journal of Lipid Research, Vol. 45, 716-728, April 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Preß high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice
Ji-Young Lee*,
Lorraine Lanningham-Foster*,
Elena Y. Boudyguina*,
Thomas L. Smith ,
Ellen R. Young*,
Perry L. Colvin ,
Michael J. Thomas** and
John S. Parks1,*
* Departments of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157
Orthopedic Surgery, Wake Forest University School of Medicine, Winston-Salem, NC 27157
** Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157
Division of Gerontology, University of Maryland School of Medicine, and Geriatrics Research, Education, and Clinical Center, Baltimore Veterans Affairs Medical Center, Baltimore, MD 21201
1 To whom correspondence should be addressed. e-mail: jparks{at}wfubmc.edu
We compared the in vivo metabolism of preß HDL particles isolated by anti-human apolipoprotein A-I (apoA-I) immunoaffinity chromatography (LpA-I) in human apoA-I transgenic (hA-I Tg) mice with that of lipid-free apoA-I (LFA-I) and small LpA-I. After injection, preß LpA-I were removed from plasma more rapidly than were LFA-I and small LpA-I. Preß LpA-I and LFA-I were preferentially degraded by kidney compared with liver; small LpA-I were preferentially degraded by the liver. Five minutes after tracer injection, 99% of LFA-I in plasma was found to be associated with medium-sized (8.6 nm) HDL, whereas only 37% of preß tracer remodeled to medium-sized HDL. Injection of preß LpA-I doses into C57Bl/6 recipients resulted in a slower plasma decay compared with hA-I Tg recipients and a greater proportion (>60%) of the preß radiolabel that was associated with medium-sized HDL. Preß LpA-I contained one to four molecules of phosphatidylcholine per molecule of apoA-I, whereas LFA-I contained less than one.
We conclude that preß LpA-I has two metabolic fates in vivo, rapid removal from plasma and catabolism by kidney or remodeling to medium-sized HDL, which we hypothesize is determined by the amount of lipid associated with the preß particle and the particle's ability to bind to medium-sized HDL.
Abbreviations: apoA-I, apolipoprotein A-I; CETP, cholesteryl ester transfer protein; FCR, fractional catabolic rate; FPLC, fast-protein liquid chromatography; hA-I Tg, human apolipoprotein A-I transgenic; HL, hepatic lipase; LFA-I, lipid-free apolipoprotein A-I; LpA-I, HDL particles isolated by anti-human apolipoprotein A-I immunoaffinity chromatography; PC, phosphatidylcholine; PLTP, phospholipid transfer protein; RCT, reverse cholesterol transport; TC, tyramine cellobiose Supplementary key words high density lipoprotein metabolism in vivo lipid-free apolipoprotein A-I fractional catabolic rate turnover die-away immunoaffinity chromatography high density lipoprotein subfractions

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Mulya, J.-Y. Lee, A. K. Gebre, E. Y. Boudyguina, S.-K. Chung, T. L. Smith, P. L. Colvin, X.-C. Jiang, and J. S. Parks
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL
J. Lipid Res.,
November 1, 2008;
49(11):
2390 - 2401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Moerland, H. Samyn, T. van Gent, M. Jauhiainen, J. Metso, R. van Haperen, F. Grosveld, A. van Tol, and R. de Crom
Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice
J. Lipid Res.,
December 1, 2007;
48(12):
2622 - 2631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mulya, J.-Y. Lee, A. K. Gebre, M. J. Thomas, P. L. Colvin, and J. S. Parks
Minimal Lipidation of Pre-{beta} HDL by ABCA1 Results in Reduced Ability to Interact with ABCA1
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2007;
27(8):
1828 - 1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Lee, R. M. Badeau, A. Mulya, E. Boudyguina, A. K. Gebre, T. L. Smith, and J. S. Parks
Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice
J. Lipid Res.,
May 1, 2007;
48(5):
1052 - 1061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Lee, J. M. Timmins, A. Mulya, T. L. Smith, Y. Zhu, E. M. Rubin, J. W. Chisholm, P. L. Colvin, and J. S. Parks
HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney
J. Lipid Res.,
October 1, 2005;
46(10):
2233 - 2245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. de Beer, D. van der Westhuyzen, N. L. Whitaker, N. R. Webb, and F. C. de Beer
SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
J. Lipid Res.,
October 1, 2005;
46(10):
2143 - 2150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Krimbou, H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest
Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines
J. Lipid Res.,
August 1, 2005;
46(8):
1668 - 1677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soderlund, A. Soro-Paavonen, C. Ehnholm, M. Jauhiainen, and M.-R. Taskinen
Hypertriglyceridemia is associated with pre{beta}-HDL concentrations in subjects with familial low HDL
J. Lipid Res.,
August 1, 2005;
46(8):
1643 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Webb, M. C. de Beer, B. F. Asztalos, N. Whitaker, D. R. van der Westhuyzen, and F. C. de Beer
Remodeling of HDL remnants generated by scavenger receptor class B type I
J. Lipid Res.,
September 1, 2004;
45(9):
1666 - 1673.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|